View More View Less
  • 1 Shahid Beheshti University of Medical Sciences Endocrine Physiology Research Center, Research Institute for Endocrine Sciences 24 Parvaneh street Velenjak, Tehran Iran PO box: 19395-4763
  • 2 Shahid Beheshti University of Medical Sciences Endocrine Research Center, Research Institute for Endocrine Sciences Tehran Iran
  • 3 Shahid Beheshti University of Medical Sciences Department of Medical Laboratory Sciences, Faculty of Paramedical Sciences Tehran Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

Diabetes is one of the five leading causes of death in the world, with type 2 diabetes occurring more frequently than type 1. Management of diabetes without side effects is still a challenge and therefore new strategies need to be examined. Because of difficulties in human research, animal models of diabetes are useful research tools for this purpose and rodent models of type 2 diabetes are the first choice. The aim of this study is an overview on one of the most frequently used models of type 2 diabetes in rat, induced by streptozotocin and nicotinamide, considering its advantages and disadvantages for diabetes research in humans.

  • Ananda PK, Kumarappan CT, Christudas S, Kalaichelvan VK: Effect of Biophytum sensitivum on streptozotocin and nicotinamide-induced diabetic rats. Asian Pac. J. Trop. Biomed. 2, 31–35 (2012)

    Kalaichelvan V.K. , 'Effect of Biophytum sensitivum on streptozotocin and nicotinamide-induced diabetic rats ' (2012 ) 2 Asian Pac. J. Trop. Biomed. : 31 -35.

    • Search Google Scholar
  • Annadurai T, Muralidharan AR, Joseph T, Hsu MJ, Thomas PA, Geraldine P: Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats. J. Physiol. Biochem. 68, 307–318 (2012)

    Geraldine P. , 'Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats ' (2012 ) 68 J. Physiol. Biochem. : 307 -318.

    • Search Google Scholar
  • Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL: Neonatal streptozotocin-induced rat model of type 2 diabetes mellitus: A glance. Indian J. Pharmacol. 36, 217 (2004)

    Bodhankar S.L. , 'Neonatal streptozotocin-induced rat model of type 2 diabetes mellitus: A glance ' (2004 ) 36 Indian J. Pharmacol. : 217 -.

    • Search Google Scholar
  • Atkins RC, Zimmet P: Diabetic kidney disease: act now or pay later. Acta Physiol. Hung. 97, 52–56 (2010)

    Zimmet P. , 'Diabetic kidney disease: act now or pay later ' (2010 ) 97 Acta Physiol. Hung. : 52 -56.

    • Search Google Scholar
  • Badole SL, Mahamuni SP, Bagul PP, Khose RD, Joshi AC, Ghule AE, Bodhankar SL, Raut CG, Khedkar VM, Coutinho EC, Wagh NK: Cycloart-23-ene-3beta, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach. Eur. J. Pharmacol. 698, 470–479 (2013)

    Wagh N.K. , 'Cycloart-23-ene-3beta, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin-nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach ' (2013 ) 698 Eur. J. Pharmacol. : 470 -479.

    • Search Google Scholar
  • Battell ML, Rodrigues B, Yuen VG, Mcneil JH (1999): Treatment and pharmacological interventions in streptozotocin diabetes. In: Experimental models of diabetes, eds Mcneil JH, CRC Press LLC, Florida, pp. 195–216

    Mcneil J.H. , '', in Experimental models of diabetes , (1999 ) -.

  • Bedoya FJ, Solano F, Lucas M: N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia 52, 344–347 (1996)

    Lucas M. , 'N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets ' (1996 ) 52 Experientia : 344 -347.

    • Search Google Scholar
  • Behme MT: Nicotinamide and diabetes prevention. Nutr. Rev. 53, 137–139 (1995)

    Behme M.T. , 'Nicotinamide and diabetes prevention ' (1995 ) 53 Nutr. Rev. : 137 -139.

  • Bennett RA, Pegg AE: Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res. 41, 2786–2790 (1981)

    Pegg A.E. , 'Alkylation of DNA in rat tissues following administration of streptozotocin ' (1981 ) 41 Cancer Res. : 2786 -2790.

    • Search Google Scholar
  • Bolzan AD, Bianchi MS: Genotoxicity of streptozotocin. Mutat. Res. 512, 121–134 (2002)

    Bianchi M.S. , 'Genotoxicity of streptozotocin ' (2002 ) 512 Mutat. Res. : 121 -134.

  • Bonner-Weir S: Islet growth and development in the adult. J. Mol. Endocrinol. 24, 297–302 (2000)

    Bonner-Weir S. , 'Islet growth and development in the adult ' (2000 ) 24 J. Mol. Endocrinol. : 297 -302.

    • Search Google Scholar
  • Bonner-Weir S: Life and death of the pancreatic beta cells. Trends Endocrinol. Metab. 11, 375–378 (2000)

    Bonner-Weir S. , 'Life and death of the pancreatic beta cells ' (2000 ) 11 Trends Endocrinol. Metab. : 375 -378.

    • Search Google Scholar
  • Bonner-Weir S: Perspective: Postnatal pancreatic beta cell growth. Endocrinology 141, 1926–1929 (2000)

    Bonner-Weir S. , 'Perspective: Postnatal pancreatic beta cell growth ' (2000 ) 141 Endocrinology : 1926 -1929.

    • Search Google Scholar
  • Bonner-Weir S (2004): Endocrine Pancreas. In: Encyclopedia of Gastroenterology, eds Johnson LR, Elsevier, New York, pp. 675–680

    Bonner-Weir S. , '', in Encyclopedia of Gastroenterology , (2004 ) -.

  • Broca C, Gross R, Petit P, Sauvaire Y, Manteghetti M, Tournier M, Masiello P, Gomis R, Ribes G: 4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am. J. Physiol. 277, E617–E623 (1999)

    Ribes G. , '4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties ' (1999 ) 277 Am. J. Physiol. : E617 -E623.

    • Search Google Scholar
  • Candela S, Hernandez RE, Gagliardino JJ: Circadian variation of the streptozotocin-diabetogenic effect in mice. Experientia 35, 1256–1257 (1979)

    Gagliardino J.J. , 'Circadian variation of the streptozotocin-diabetogenic effect in mice ' (1979 ) 35 Experientia : 1256 -1257.

    • Search Google Scholar
  • Chang KC, Tseng CD, Chou TF, Cho YL, Chi TC, Su MJ, Tseng YZ: Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes. Eur. J. Clin. Invest. 36, 1–7 (2006)

    Tseng Y.Z. , 'Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes ' (2006 ) 36 Eur. J. Clin. Invest. : 1 -7.

    • Search Google Scholar
  • Chang KC, Tseng CD, Wu MS, Liang JT, Tsai MS, Cho YL, Tseng YZ: Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes. Eur. J. Clin. Invest. 36, 528–535 (2006)

    Tseng Y.Z. , 'Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes ' (2006 ) 36 Eur. J. Clin. Invest. : 528 -535.

    • Search Google Scholar
  • Chatzigeorgiou A, Halapas A, Kalafatakis K, Kamper E: The use of animal models in the study of diabetes mellitus. In Vivo 23, 245–258 (2009)

    Kamper E. , 'The use of animal models in the study of diabetes mellitus ' (2009 ) 23 In Vivo : 245 -258.

    • Search Google Scholar
  • Chen D, Wang MW: Development and application of rodent models for type 2 diabetes. Diabetes Obes. Metab. 7, 307–317 (2005)

    Wang M.W. , 'Development and application of rodent models for type 2 diabetes ' (2005 ) 7 Diabetes Obes. Metab. : 307 -317.

    • Search Google Scholar
  • Chen L, Magliano DJ, Zimmet PZ: The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat. Rev. Endocrinol. 8, 228–236 (2012)

    Zimmet P.Z. , 'The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives ' (2012 ) 8 Nat. Rev. Endocrinol. : 228 -236.

    • Search Google Scholar
  • Chi TC, Chen WP, Chi TL, Kuo TF, Lee SS, Cheng JT, Su MJ: Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci. 80, 1713–1720 (2007)

    Su M.J. , 'Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats ' (2007 ) 80 Life Sci. : 1713 -1720.

    • Search Google Scholar
  • Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL, Kudva YC: Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab. Anim. 45, 131–140 (2011)

    Kudva Y.C. , 'Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models ' (2011 ) 45 Lab. Anim. : 131 -140.

    • Search Google Scholar
  • Eizirik DL, Migliorini RH: Reduced diabetogenic effect of streptozotocin in rats previously adapted to a high-protein, carbohydrate-free diet. Diabetes 33, 383–388 (1984)

    Migliorini R.H. , 'Reduced diabetogenic effect of streptozotocin in rats previously adapted to a high-protein, carbohydrate-free diet ' (1984 ) 33 Diabetes : 383 -388.

    • Search Google Scholar
  • Elshal MF, Kumosani TA, Abulnaja KO: Influence of defatted flaxseed diet on insulin sensitivity, vascular permeability and lipid profile in a rat model of type 2 diabetes mellitus. J. Med. Plants Res. 6, 2188–2193 (2012)

    Abulnaja K.O. , 'Influence of defatted flaxseed diet on insulin sensitivity, vascular permeability and lipid profile in a rat model of type 2 diabetes mellitus ' (2012 ) 6 J. Med. Plants Res. : 2188 -2193.

    • Search Google Scholar
  • Fierabracci V, De Tata V, Pocai A, Novelli M, Barbera A, Masiello P: Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes. Endocrine 19, 177–184 (2002)

    Masiello P. , 'Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes ' (2002 ) 19 Endocrine : 177 -184.

    • Search Google Scholar
  • Haluzik M, Nedvidkova J: The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications. Physiol. Res. 49 Suppl 1, S37–42 (2000)

    Nedvidkova J. , 'The role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implications ' (2000 ) 49 Physiol. Res. : S37 -42.

    • Search Google Scholar
  • Hu YY, Ye SD: Experimental models of type 2 diabetic nephropathy. Chin. Med. J. (Engl) 126, 574–577 (2013)

    Ye S.D. , 'Experimental models of type 2 diabetic nephropathy ' (2013 ) 126 Chin. Med. J. (Engl) : 574 -577.

    • Search Google Scholar
  • Hypponen E: Micronutrients and the risk of type 1 diabetes: vitamin D, vitamin E, and nicotinamide. Nutr. Rev. 62, 340–347 (2004)

    Hypponen E. , 'Micronutrients and the risk of type 1 diabetes: vitamin D, vitamin E, and nicotinamide ' (2004 ) 62 Nutr. Rev. : 340 -347.

    • Search Google Scholar
  • Irons BK, Minze MG: Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated. Diabetes Metab. Syndr. Obes. 7, 15–24 (2014)

    Minze M.G. , 'Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated ' (2014 ) 7 Diabetes Metab. Syndr. Obes. : 15 -24.

    • Search Google Scholar
  • Islam MS, Wilson RD (2012): Experimentally induced rodent models of type 2 diabetes. In: Animal Models in Diabetes Research, eds Joost H-G, Al-Hasani H, Schürmann A, Humana Press, New York, pp. 161–174

    Wilson R.D. , '', in Animal Models in Diabetes Research , (2012 ) -.

  • Junod A, Lambert AE, Stauffacher W, Renold AE: Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J. Clin. Invest. 48, 2129 (1969)

    Renold A.E. , 'Diabetogenic action of streptozotocin: relationship of dose to metabolic response ' (1969 ) 48 J. Clin. Invest. : 2129 -.

    • Search Google Scholar
  • Karunanayake EH, Hearse DJ, Mellows G: Streptozotocin: its excretion and metabolism in the rat. Diabetologia 12, 483–488 (1976)

    Mellows G. , 'Streptozotocin: its excretion and metabolism in the rat ' (1976 ) 12 Diabetologia : 483 -488.

    • Search Google Scholar
  • Kim KA, Kim S, Chang I, Kim GS, Min YK, Lee MK, Kim KW, Lee MS: IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis. Diabetologia 45, 385–393 (2002)

    Lee M.S. , 'IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis ' (2002 ) 45 Diabetologia : 385 -393.

    • Search Google Scholar
  • Krentz AJ, Bailey CJ: Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 65, 385–411 (2005)

    Bailey C.J. , 'Oral antidiabetic agents: current role in type 2 diabetes mellitus ' (2005 ) 65 Drugs : 385 -411.

    • Search Google Scholar
  • Kuntz E, Pinget M, Damge C: Effects of cholecystokinin octapeptide on the exocrine pancreas in a new rat model of type 2 diabetes. Eur. J. Pharmacol. 448, 253–261 (2002)

    Damge C. , 'Effects of cholecystokinin octapeptide on the exocrine pancreas in a new rat model of type 2 diabetes ' (2002 ) 448 Eur. J. Pharmacol. : 253 -261.

    • Search Google Scholar
  • L’abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, Barsacchi R, Paolicchi A, Masiello P, Drummond GS, Mcclung JA, Abraham NG: Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 293, H3532–H3541 (2007)

    Abraham N.G. , 'Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats ' (2007 ) 293 Am. J. Physiol. Heart Circ. Physiol. : H3532 -H3541.

    • Search Google Scholar
  • Lenzen S: The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51, 216–226 (2008)

    Lenzen S. , 'The mechanisms of alloxan- and streptozotocin-induced diabetes ' (2008 ) 51 Diabetologia : 216 -226.

    • Search Google Scholar
  • Li HT, Wu XD, Davey AK, Wang J: Antihyperglycemic effects of baicalin on streptozotocin — nicotinamide induced diabetic rats. Phytother. Res. 25, 189–194 (2011)

    Wang J. , 'Antihyperglycemic effects of baicalin on streptozotocin — nicotinamide induced diabetic rats ' (2011 ) 25 Phytother. Res. : 189 -194.

    • Search Google Scholar
  • Maiese K, Chong ZZ, Hou J, Shang YC: The vitamin nicotinamide: translating nutrition into clinical care. Molecules 14, 3446–3485 (2009)

    Shang Y.C. , 'The vitamin nicotinamide: translating nutrition into clinical care ' (2009 ) 14 Molecules : 3446 -3485.

    • Search Google Scholar
  • Masiello P: Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int. J. Biochem. Cell. Biol. 38, 873–893 (2006)

    Masiello P. , 'Animal models of type 2 diabetes with reduced pancreatic beta-cell mass ' (2006 ) 38 Int. J. Biochem. Cell. Biol. : 873 -893.

    • Search Google Scholar
  • Masiello P, Bergamini E: Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the effectiveness of the protection. Experientia 33, 1246–1247 (1977)

    Bergamini E. , 'Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the effectiveness of the protection ' (1977 ) 33 Experientia : 1246 -1247.

    • Search Google Scholar
  • Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G: Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47, 224–229 (1998)

    Ribes G. , 'Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide ' (1998 ) 47 Diabetes : 224 -229.

    • Search Google Scholar
  • Murugan P, Pari L: Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sci. 79, 1720–1728 (2006)

    Pari L. , 'Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats ' (2006 ) 79 Life Sci. : 1720 -1728.

    • Search Google Scholar
  • Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32, 193–203 (2009)

    Zinman B. , 'Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes ' (2009 ) 32 Diabetes Care : 193 -203.

    • Search Google Scholar
  • Novelli M, Fabregat ME, Fernandez-Alvarez J, Gomis R, Masiello P: Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes. Mol. Cell. Endocrinol. 175, 57–66 (2001)

    Masiello P. , 'Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes ' (2001 ) 175 Mol. Cell. Endocrinol. : 57 -66.

    • Search Google Scholar
  • Novelli M, Pocai A, Lajoix AD, Beffy P, Bezzi D, Marchetti P, Gross R, Masiello P: Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes. Mol. Cell. Endocrinol. 219, 77–82 (2004)

    Masiello P. , 'Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes ' (2004 ) 219 Mol. Cell. Endocrinol. : 77 -82.

    • Search Google Scholar
  • Ortiz-Andrade RR, Sanchez-Salgado JC, Navarrete-Vazquez G, Webster SP, Binnie M, Garcia-Jimenez S, Leon-Rivera I, Cigarroa-Vazquez P, Villalobos-Molina R, Estrada-Soto S: Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes. Metab. 10, 1097–1104 (2008)

    Estrada-Soto S. , 'Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation ' (2008 ) 10 Diabetes Obes. Metab. : 1097 -1104.

    • Search Google Scholar
  • Ortiz PA, Garvin JL: Role of nitric oxide in the regulation of nephron transport. Am. J. Physiol. Renal. Physiol. 282, F777–F784 (2002)

    Garvin J.L. , 'Role of nitric oxide in the regulation of nephron transport ' (2002 ) 282 Am. J. Physiol. Renal. Physiol. : F777 -F784.

    • Search Google Scholar
  • Palsamy P, Sivakumar S, Subramanian S: Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats. Chem. Biol. Interact. 186, 200–210 (2010)

    Subramanian S. , 'Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats ' (2010 ) 186 Chem. Biol. Interact. : 200 -210.

    • Search Google Scholar
  • Palsamy P, Subramanian S: Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Chem. Biol. Interact. 179, 356–362 (2009)

    Subramanian S. , 'Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats ' (2009 ) 179 Chem. Biol. Interact. : 356 -362.

    • Search Google Scholar
  • Palsamy P, Subramanian S: Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J. Cell. Physiol. 224, 423–432 (2010)

    Subramanian S. , 'Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats ' (2010 ) 224 J. Cell. Physiol. : 423 -432.

    • Search Google Scholar
  • Palsamy P, Subramanian S: Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim. Biophys. Acta 1812, 719–731 (2011)

    Subramanian S. , 'Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling ' (2011 ) 1812 Biochim. Biophys. Acta : 719 -731.

    • Search Google Scholar
  • Pandya KG, Patel MR, Lau-Cam CA: Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide. J. Biomed. Sci. 17 Suppl 1, S16 (2010)

    Lau-Cam C.A. , 'Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide ' (2010 ) 17 J. Biomed. Sci. : S16 -.

    • Search Google Scholar
  • Pari L, Karthikesan K, Menon VP: Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes. Mol. Cell. Biochem. 341, 109–117 (2010)

    Menon V.P. , 'Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes ' (2010 ) 341 Mol. Cell. Biochem. : 109 -117.

    • Search Google Scholar
  • Pari L, Sankaranarayanan C: Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats. Life Sci. 85, 830–834 (2009)

    Sankaranarayanan C. , 'Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats ' (2009 ) 85 Life Sci. : 830 -834.

    • Search Google Scholar
  • Pari L, Saravanan R: Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes. Chem. Biol. Interact. 169, 15–24 (2007)

    Saravanan R. , 'Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes ' (2007 ) 169 Chem. Biol. Interact. : 15 -24.

    • Search Google Scholar
  • Pari L, Satheesh MA: Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats. Life Sci. 79, 641–645 (2006)

    Satheesh M.A. , 'Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats ' (2006 ) 79 Life Sci. : 641 -645.

    • Search Google Scholar
  • Pari L, Srinivasan S: Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Biomed. Pharmacother. 64, 477–481 (2010)

    Srinivasan S. , 'Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats ' (2010 ) 64 Biomed. Pharmacother. : 477 -481.

    • Search Google Scholar
  • Pari L, Suman S: Efficacy of naringin on hepatic enzymes of carbohydrate metabolism in streptozotocin-nicotinamide induced type 2 diabetic rats. Int. J. Pharm. Biol. Arch. 1, 280–286 (2010)

    Suman S. , 'Efficacy of naringin on hepatic enzymes of carbohydrate metabolism in streptozotocin-nicotinamide induced type 2 diabetic rats ' (2010 ) 1 Int. J. Pharm. Biol. Arch. : 280 -286.

    • Search Google Scholar
  • Pierre W, Gildas AJ, Ulrich MC, Modeste WN, Benoit NT, Albert K: Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats. BMC Complement Altern. Med. 12, 264 (2012)

    Albert K. , 'Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats ' (2012 ) 12 BMC Complement Altern. Med. : 264 -.

    • Search Google Scholar
  • Pitkin RM, Reynolds WA: Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes 19, 85–90 (1970)

    Reynolds W.A. , 'Diabetogenic effects of streptozotocin in rhesus monkeys ' (1970 ) 19 Diabetes : 85 -90.

    • Search Google Scholar
  • Pociot F, Reimers JI, Andersen HU: Nicotinamide biological actions and therapeutic potential in diabetes prevention. IDIG Workshop, Copenhagen, Denmark, 4–5 December 1992. Diabetologia 36, 574–576 (1993)

    Andersen H.U. , 'Nicotinamide biological actions and therapeutic potential in diabetes prevention. ' (1993 ) 36 Diabetologia : 574 -576.

    • Search Google Scholar
  • Rabbani SI, Devi K, Khanam S: Inhibitory effect of glimepiride on nicotinamide-streptozotocin induced nuclear damages and sperm abnormality in diabetic Wistar rats. Indian J. Exp. Biol. 47, 804–810 (2009)

    Khanam S. , 'Inhibitory effect of glimepiride on nicotinamide-streptozotocin induced nuclear damages and sperm abnormality in diabetic Wistar rats ' (2009 ) 47 Indian J. Exp. Biol. : 804 -810.

    • Search Google Scholar
  • Rajarajeswari N, Pari L: Antioxidant role of coumarin on streptozotocin-nicotinamide-induced type 2 diabetic rats. J. Biochem. Mol. Toxicol. 25, 355–361 (2011)

    Pari L. , 'Antioxidant role of coumarin on streptozotocin-nicotinamide-induced type 2 diabetic rats ' (2011 ) 25 J. Biochem. Mol. Toxicol. : 355 -361.

    • Search Google Scholar
  • Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM: A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49, 1390–1394 (2000)

    Reaven G.M. , 'A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat ' (2000 ) 49 Metabolism : 1390 -1394.

    • Search Google Scholar
  • Rees DA, Alcolado JC: Animal models of diabetes mellitus. Diabet. Med. 22, 359–370 (2005)

    Alcolado J.C. , 'Animal models of diabetes mellitus ' (2005 ) 22 Diabet. Med. : 359 -370.

  • Rodrigues B, Poucheret P, Battell ML, Mcneil JH (1999): Streptozotocin-induced diabetes: induction, mechanism(s), and dose dependency. In: Experimental Models of Diabetes, eds Mcneil JH, CRC Press LLC, Florida, pp. 3–17

    Mcneil J.H. , '', in Experimental Models of Diabetes , (1999 ) -.

  • Sharma AK, Sharma A, Kumari R, Kishore K, Sharma D, Srinivasan BP, Singh SK, Gaur S, Jatav VS, Sharma P, Srivastava V, Joshi S, Joshi M, Dhakad PK, Kanawat DS, Mishra A, Singh D, Singh RP, Chawda HS, Singh R, Raikwar SK, Kurmi MK, Khatri P, Agarwal A, Munajjam A: Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats. J. Biomed. Res. 26, 200–210 (2012)

    Munajjam A. , 'Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats ' (2012 ) 26 J. Biomed. Res. : 200 -210.

    • Search Google Scholar
  • Sheela N, Jose MA, Sathyamurthy D, Kumar BN: Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. Iran J. Kidney Dis. 7, 117–123 (2013)

    Kumar B.N. , 'Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats ' (2013 ) 7 Iran J. Kidney Dis. : 117 -123.

    • Search Google Scholar
  • Shirwaikar A, Rajendran K, Barik R: Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocinnicotinamide induced type-II diabetes mellitus. J. Ethnopharmacol. 107, 285–290 (2006)

    Barik R. , 'Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocinnicotinamide induced type-II diabetes mellitus ' (2006 ) 107 J. Ethnopharmacol. : 285 -290.

    • Search Google Scholar
  • Siddiqui BS, Hasan M, Mairaj F, Mehmood I, Hafizur RM, Hameed A, Khan Shinwari Z: Two new compounds from the aerial parts of Bergenia himalaica Boriss and their anti-hyperglycemic effect in streptozotocin-nicotinamide induced diabetic rats. J. Ethnopharmacol. 152, 561–567 (2014)

    Khan Shinwari Z. , 'Two new compounds from the aerial parts of Bergenia himalaica Boriss and their anti-hyperglycemic effect in streptozotocin-nicotinamide induced diabetic rats ' (2014 ) 152 J. Ethnopharmacol. : 561 -567.

    • Search Google Scholar
  • Srinivasan K, Ramarao P: Animal models in type 2 diabetes research: an overview. Indian J. Med. Res. 125, 451–472 (2007)

    Ramarao P. , 'Animal models in type 2 diabetes research: an overview ' (2007 ) 125 Indian J. Med. Res. : 451 -472.

    • Search Google Scholar
  • Su HC, Hung LM, Chen JK: Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290, E1339–E1346 (2006)

    Chen J.K. , 'Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats ' (2006 ) 290 Am. J. Physiol. Endocrinol. Metab. : E1339 -E1346.

    • Search Google Scholar
  • Szkudelska K, Nogowski L, Szkudelski T: Adipocyte dysfunction in rats with streptozotocin-nicotinamide-induced diabetes. Int. J. Exp. Pathol. 95, 86–94 (2014)

    Szkudelski T. , 'Adipocyte dysfunction in rats with streptozotocin-nicotinamide-induced diabetes ' (2014 ) 95 Int. J. Exp. Pathol. : 86 -94.

    • Search Google Scholar
  • Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50, 537–546 (2001)

    Szkudelski T. , 'The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas ' (2001 ) 50 Physiol. Res. : 537 -546.

    • Search Google Scholar
  • Szkudelski T: Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp. Biol. Med. (Maywood) 237, 481–490 (2012)

    Szkudelski T. , 'Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model ' (2012 ) 237 Exp. Biol. Med. (Maywood) : 481 -490.

    • Search Google Scholar
  • Taha H, Arya A, Paydar M, Looi CY, Wong WF, Vasudeva Murthy CR, Noordin MI, Ali HM, Mustafa AM, Hadi AH: Upregulation of insulin secretion and downregulation of pro-inflammatory cytokines, oxidative stress and hyperglycemia in STZ-nicotinamide-induced type 2 diabetic rats by Pseuduvaria monticola bark extract. Food Chem. Toxicol. 66, 295–306 (2014)

    Hadi A.H. , 'Upregulation of insulin secretion and downregulation of pro-inflammatory cytokines, oxidative stress and hyperglycemia in STZ-nicotinamide-induced type 2 diabetic rats by Pseuduvaria monticola bark extract ' (2014 ) 66 Food Chem. Toxicol. : 295 -306.

    • Search Google Scholar
  • Tay YC, Wang Y, Kairaitis L, Rangan GK, Zhang C, Harris DC: Can murine diabetic nephropathy be separated from superimposed acute renal failure? Kidney Int. 68, 391–398 (2005)

    Harris D.C. , 'Can murine diabetic nephropathy be separated from superimposed acute renal failure? ' (2005 ) 68 Kidney Int. : 391 -398.

    • Search Google Scholar
  • Torres-Piedra M, Ortiz-Andrade R, Villalobos-Molina R, Singh N, Medina-Franco JL, Webster SP, Binnie M, Navarrete-Vazquez G, Estrada-Soto S: A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition. Eur. J. Med. Chem. 45, 2606–2612 (2010)

    Estrada-Soto S. , 'A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition ' (2010 ) 45 Eur. J. Med. Chem. : 2606 -2612.

    • Search Google Scholar
  • Weng Y, Yu L, Cui J, Zhu YR, Guo C, Wei G, Duan JL, Yin Y, Guan Y, Wang YH, Yang ZF, Xi MM, Wen AD: Antihyperglycemic, hypolipidemic and antioxidant activities of total saponins extracted from Aralia taibaiensis in experimental type 2 diabetic rats. J. Ethnopharmacol. 152, 553–560 (2014)

    Wen A.D. , 'Antihyperglycemic, hypolipidemic and antioxidant activities of total saponins extracted from Aralia taibaiensis in experimental type 2 diabetic rats ' (2014 ) 152 J. Ethnopharmacol. : 553 -560.

    • Search Google Scholar

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2020 0 100 132
Jun 2020 0 5 7
Jul 2020 42 6 7
Aug 2020 46 0 0
Sep 2020 46 0 0
Oct 2020 20 0 0
Nov 2020 0 0 0